Spyglass Pharma Inc (SGP)

May 24, 2026

Spyglass Pharma (SGP) Stock Chart and Price History 2026 $SGP - MarketBeat

May 24, 2026

May 21, 2026

SpyGlass Pharma to Participate in Upcoming Investor Conferences - The Manila Times

May 21, 2026

May 21, 2026

SpyGlass Pharma execs set for three June healthcare investor events - Stock Titan

May 21, 2026

May 19, 2026

SpyGlass Pharma: New add-on CPT code supports BIM-IOL System - Eyes On Eyecare

May 19, 2026

May 19, 2026

SpyGlass Secures Billing Code for IOL Platform - Orange County Business Journal

May 19, 2026

May 18, 2026

Spyglass Pharma IncBIM-Iol System Phase 3 Trial Enrollment Expected To Complete In 2027 - TradingView

May 18, 2026

May 18, 2026

Eye surgeons get new code for implant treating glaucoma during cataract surgery - Stock Titan

May 18, 2026

May 18, 2026

Spyglass Pharma (SGP) Earnings Date and Reports 2026 $SGP - MarketBeat

May 18, 2026

May 17, 2026

SpyGlass Pharma (SGP) Q1 2026 Earnings Miss by Significant: Key TakeawaysBuyback Authorization - newser.com

May 17, 2026

May 15, 2026

SpyGlass Pharma posts Q1 loss as Phase 3 trials advance By Investing.com - Investing.com South Africa

May 15, 2026

May 15, 2026

SpyGlass Pharma posts Q1 loss as Phase 3 trials advance - Investing.com India

May 15, 2026

May 15, 2026

SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates - Sahm

May 15, 2026

May 15, 2026

Number of shareholders of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView

May 15, 2026

May 14, 2026

SpyGlass Pharma (SGP) boosts cash to $251M after IPO while losses widen - Stock Titan

May 14, 2026

May 14, 2026

SpyGlass Pharma (SGP) boosts cash with IPO and reports strong BIM-IOL glaucoma data - Stock Titan

May 14, 2026

May 14, 2026

SpyGlass Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026

May 14, 2026

Spyglass Pharma (SGP) Institutional Ownership 2026 $SGP - MarketBeat

May 14, 2026

May 14, 2026

Eye implant ended IOP-lowering drops for 98% in trial - Stock Titan

May 14, 2026

May 05, 2026

SGP SpyGlass Pharma reports solid late-stage trial progress, lays out aggressive commercial expansion plans for 2025.Stock Community Signals - newser.com

May 05, 2026

May 01, 2026

What fair value gap SpyGlass Pharma (SGP)? (Buying Pressure) 2026-05-01VWAP Bounce - Newser

May 01, 2026

Apr 29, 2026

SGP Ownership | SPYGLASS PHARMA INC (NASDAQ:SGP) - ChartMill

Apr 29, 2026

Apr 27, 2026

Eye care firm SpyGlass Pharma soars 65% in trading debut - MSN

Apr 27, 2026

Apr 17, 2026

SGP Technical Analysis | Trend, Signals & Chart Patterns | SPYGLASS PHARMA INC (NASDAQ:SGP) - ChartMill

Apr 17, 2026

Apr 12, 2026

All News for SGP : SpyGlass Pharma, Inc. - Zacks Investment Research

Apr 12, 2026

Apr 12, 2026

Dividend HistorySpyGlass Pharma, Inc. (SGP) - Zacks Investment Research

Apr 12, 2026

Apr 06, 2026

Is SpyGlass Pharma (SGP) Stock Good for Long Term | Price at $22.30, Down 0.71%Social Buy Zones - Newser

Apr 06, 2026

Apr 05, 2026

SpyGlass Pharma, Inc.: Fundamental Analysis and Financial Ratings | SGP | US85220G1094 - marketscreener.com

Apr 05, 2026

Apr 02, 2026

SGP: SpyGlass Pharma, Inc.Insider Transations - Zacks Investment Research

Apr 02, 2026

Mar 31, 2026

SpyGlass Pharma, Inc. (SGP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Mar 31, 2026

Mar 30, 2026

SpyGlass Pharma Reports Fourth Quarter and Full-Year 2025 Results - VisionMonday.com

Mar 30, 2026

Mar 29, 2026

SpyGlass Pharma, Inc. (SGP) stock price, news, quote and history - Yahoo Finance UK

Mar 29, 2026

Mar 27, 2026

Stifel reiterates Buy on SpyGlass Pharma stock, $42 target By Investing.com - Investing.com Canada

Mar 27, 2026

Mar 27, 2026

Stifel reiterates Buy on SpyGlass Pharma stock, $42 target - Investing.com

Mar 27, 2026

Mar 27, 2026

SpyGlass Pharma’s BIM-IOL System: Transforming Glaucoma and Ocular Hypertension Treatment with Long-Acting Drug Delivery Solutions - Minichart

Mar 27, 2026

Mar 26, 2026

SpyGlass Pharma (NASDAQ: SGP) outlines long-acting glaucoma implant pipeline - Stock Titan

Mar 26, 2026

Mar 26, 2026

[8-K] SpyGlass Pharma, Inc. Reports Material Event - Stock Titan

Mar 26, 2026

Mar 26, 2026

97% stopped glaucoma drops in SpyGlass eye implant study - Stock Titan

Mar 26, 2026

Mar 24, 2026

New Glaucoma Treatment Uses Eye Implant for Three-Year Drug Delivery - University of Colorado Anschutz

Mar 24, 2026

Mar 22, 2026

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to S&P TMI Index - marketscreener.com

Mar 22, 2026

Mar 20, 2026

SGP Stock Price, News & Analysis - Stock Titan

Mar 20, 2026

Mar 16, 2026

SpyGlass Valued at $900M After IPO - Orange County Business Journal

Mar 16, 2026

Mar 15, 2026

Spyglass Pharma (SGP) Insider Trading Activity 2026 $SGP - MarketBeat

Mar 15, 2026

Mar 11, 2026

Spyglass Pharma (NASDAQ:SGP) Coverage Initiated by Analysts at HC Wainwright - Defense World

Mar 11, 2026

Mar 10, 2026

H.C. Wainwright initiates SpyGlass Pharma stock coverage with buy rating By Investing.com - Investing.com Canada

Mar 10, 2026

Mar 09, 2026

SpyGlass Pharma reports positive 12-month Phase 1/2 BIM-IOL results with high drop-free rates - TradingView

Mar 09, 2026

Mar 09, 2026

SpyGlass Pharma reports positive 12-month glaucoma device trial data - Investing.com Australia

Mar 09, 2026